Navigation Links
MSA Schedules Third Quarter Earnings Webcast
Date:10/24/2007

PITTSBURGH, Oct. 24 /PRNewswire-FirstCall/ -- MSA (NYSE: MSA), the global leader in the development, manufacture and supply of sophisticated products that protect people's health and safety, announced today that it will broadcast a third quarter 2007 earnings conference call live via the Internet on Thursday, November 1, 2007 at 10:00 a.m. EDT. The call will last approximately 45 minutes.

Investors and interested parties will have the opportunity to listen to the conference call live at http://www.msanet.com. Please log onto MSA's Web site 15 minutes prior to the start of the call to register. It may be necessary to download audio software to hear the conference call. To do so, investors should click on the Earnings Conference Call link on MSA's Web site and follow directions from there. A replay of the conference will be available on MSA's Web site for 30 days.

A press release outlining third quarter financial results for 2007 will be distributed on November 1, 2007 before the market opens.

Established in 1914, MSA is a global leader in the development, manufacture and supply of sophisticated safety products that protect people's health and safety. Sophisticated safety products typically integrate any combination of electronics, mechanical systems and advanced materials to protect users against hazardous or life-threatening situations. The company's comprehensive line of products is used by workers around the world in the fire service, homeland security, construction and other industries, as well as the military. Principal products include self-contained breathing apparatus, gas masks, gas detection instruments, head protection, respirators and therma
'/>"/>

SOURCE MSA
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Shorter Radiation Schedules Found To Be More Effective For Patients With Breast Cancer
2. Vaccination Schedules Rates among Canadian Kids Dip Low
3. UP Government Fixes Work Schedules for Provincial Medical Service Doctors
4. Third artificial heart patient introduced
5. Extra hormone found to cut appetite by a third
6. Third generation Small pox vaccine from Cell-culture
7. Surgery Offers Better Treatment For Third Degree Piles
8. One Third Of All Cancers Preventable!
9. Britain Announces Third Transfusion Related Mad Cow Case
10. Kleins Third Way Has Tough Opposition
11. Ignorance about AIDS rampart in Third of College Students: Chinese survey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...artery stenosis, according to a large study perfor... The Netherlands. , The study consisted of 1,33...se with 50% or more stenosis. 10,561 coronary arte...und a 98% sensitivity rate for detecting significa...ficity was 91%," said Lucia J.M. Kroft, MD, and Al...
(Date:12/1/2008)...ging technique to take high quality color photogra...in mice, and the technology could help in the moni...ay cause blindness. , The study, "The Clinical T...s Using Topical Endoscopic Fundal Imaging with His...published in the Association for Research in Visio...
(Date:12/1/2008)... $4.97 million grant from the Bill & Melinda Gates...ique program aimed at improving health outcomes in...Johns Hopkins Center for Global Health, and the Ma...mpala, Uganda. As part of the initiative, the facu...oth schools will develop an institution-building r...
(Date:12/1/2008)...e/ -- As President Bush seeks,to push through a f...ially,adversely impact healthcare services and wo.../National Nurses Organizing Committee today unveil...end Bush packing,", http://www.SendBushPacking.co...ighlighting some of the "midnight,rules" -- last ...
Breaking Medicine News(10 mins):Health News:New technique captures high-res images of full retina 2Health News:Johns Hopkins and Makerere University to collaborate on African health education initiative 2Health News:Johns Hopkins and Makerere University to collaborate on African health education initiative 3Health News:Citing 'Midnight Rules' to Erode Health and Safety, Nurses Unveil New Website to Send Bush Packing 2
... personality and looks than the size of his penis,... are average sized, according to a research review...l BJU International. Dr Kevan Wylie from the Porte...Hospital, Sheffield, UK, reports that while men of...
... step? Sleeplessness to sleepwalking to sex during...psychiatrist at the Minnesota Regional Sleep Disor..., who has been studying bizarre sleep-related diso...ears. That includes people who eat while asleep a...
... can avoid a biochemical program of self-destructi... the damage, is giving investigators at St. Jude C...rategy cancer cells use to survive and thrive. Th...a drug that disrupts a cancer cell's ability to bl...
...mily disputes regarding the latest woman in Sanjay...health , say his close friends and well-wishers. ...Anything can happen,' a close friend told IANS. T...from a serious back problem and is in a state of a...
Other Medicine News:Health News:Research Says Small Penis Syndrome Affects Men Than Women 2Health News:Research Says Small Penis Syndrome Affects Men Than Women 3Health News:Sleepwalking to sex during sleep, a new disorder detected 2Health News:Stress-Related Health Problems Haunts Sanjay Dutt 2
(Date:11/25/2008)... 25 Poniard,Pharmaceuti...company focused on,innovative oncology therapies,...gic alternatives for its preclinical research prog...esources on the clinical development of picoplatin...initial commercialization of,picoplatin in the tr...
(Date:11/24/2008)..., Nov. 24 Takeda Pharmaceutical Co...eda Global Research & Development Center, Inc....y Committee of the U.S. Food and Drug Administrati...at for the treatment of hyperuricemia in patients...proval, with one panel member abstaining. The vote...
(Date:11/24/2008)...leadership and long-term commitment to hepatitis r...wswire-FirstCall/ -- Schering-Plough Corporation (...boceprevir, its lead investigational oral hepatiti...lopment. The company believes boceprevir has the ... protease inhibitor for treating chronic hepatitis...
(Date:11/24/2008)...wswire-FirstCall/ -- GeneThera, Inc.,(Pink Sheets...its Real Time,PCR test for Johne,s disease throug...Thera is set to begin offering its Johne,s disease...ording to GeneThera Chairman, Dr. Tony Milici MD,...R test for Johne,s disease,called HerdGuard(TM) ...
Breaking Medicine Technology:Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 2Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 2GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 3GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 4Lifetime Television Launches Third Annual Dont Skip a Beat Multi Platform Heart Health Awareness Initiative 10786 1Lifetime Television Launches Third Annual Dont Skip a Beat Multi Platform Heart Health Awareness Initiative 10786 2Lifetime Television Launches Third Annual Dont Skip a Beat Multi Platform Heart Health Awareness Initiative 10786 3Election 2008 3A Sleep deprivation a tough opponent for presidential candidates 10781 1Election 2008 3A Sleep deprivation a tough opponent for presidential candidates 10781 2MDS Inc Files Restated 2007 Quarterly Reports Under US GAAP 10779 1On Heels of SCHIP Veto President Advocates Eliminating Federal Funding for Training Childrens Doctors 10775 1On Heels of SCHIP Veto President Advocates Eliminating Federal Funding for Training Childrens Doctors 10775 2
...WIRE)--Apr 18, 2007 - Nymox,Pharmaceutical Corpora...a new 42 month follow-up study of NX-1207 for beni...d symptomatic,progress of U.S. patients involved i... 2003. Individuals in the study were assessed,for ...urability of,efficacy. Patients in the study were ...
...ion for Cancer Research Annual,Meeting, SAN DIEGO,...,Pharmaceuticals, Inc. , a biopharmaceutical resea...zing proprietary product,candidates for the treatm...nced positive results from preclinical studies usi... (CoFactor(R)) at the,American Association for Can...
Other Medicine Technology:Nymox Reports Completion of New 42 Month Follow-up Study of NX-1207,for BPH 2Adventrx Announces Positive Data From Multidrug Therapy With,CoFactor 2Adventrx Announces Positive Data From Multidrug Therapy With,CoFactor 3Adventrx Announces Positive Data From Multidrug Therapy With,CoFactor 4
... of cerclage wiring, the Cable-Ready Cable Grip1 S...e minimizing invasion of the wound site. The syste... technique. , ,The Cable-Ready Cable Grip system ...y involving: Olecranon Fractures, Femur Fractures,...
The Assistant Free Self-Retaining Hip Surgery Retractor System is used for hip arthroplasty and hip fracture surgery.
The Taperloc femoral component is a collarless flat wedge-shaped implant that provides excellent durability and stability in a design that is relatively simple and predictable to implant. The incorpo
Build your Basic Small Joint Set from the suggested instruments or select other insruments for the set.
Medicine Products: